Neurology Today November 2012 Volume 12 Issue 21

November 2012 Volume 12 Issue 21
Features
contaminated lots of epidural steroid injections prompt outbreak of meningitis: advice on diagnosis & treatment from neuroinfectious disease experts. - Talan, Jamie
an antigen-specific technique halts myasthenia gravis in animal model: experts ask: could it work in humans?. - Talan, Jamie
news from the american neurological association annual meeting: eculizumab shows promise for preventing nmo attacks, keeping disease in check. - Laino, Charlene
news from the american neurological association annual meeting: narcolepsy and cataplexy circuitry becomes clearer after a decade of research. - Robinson, Richard
how does myelination maturation affect thought and behavior?: a chimp to human comparison offers new clues. - Talan, Jamie
new data confirm the role of inflammatory markers in als. - Talan, Jamie
news from the american neurological association annual meeting: anti-amyloid-beta drug modestly slows cognitive decline in mild to moderate ad. - Laino, Charlene
news from the american neurological association annual meeting: alemtuzumab phase 3 results: will superior efficacy overcome safety concerns for early treatment?. - Robinson, Richard
in small trial, mexiletine proves successful for treating myotonia. - Talan, Jamie
news from the american neurological association annual meeting: alzheimer's disease may progress at slower rate than believed. - Laino, Charlene
Departments
legal-ease: seize and desist: the ethics and legality of reporting epileptic drivers. - Kass, Joseph, MD, JD, Wax, Jennifer
in practice: should your medical records be an 'open book' to your patients? neurologists test the waters. - Avitzur, Orly, MD, MBA
news from the ninds: new nih toolbox rolled out for standardized behavioral and clinical assessment measures. - Talan, Jamie